Viva Biotech logo

Viva Biotech

Asia, Shanghai, China, Shanghai

Description

Viva Biotech is a Healthcare Start Up Based In Shanghai.

Investor Profile

Viva Biotech has made 5 investments, with 0 in the past 12 months and 40% as lead.

Stage Focus

  • Series A (40%)
  • Seed (20%)
  • Convertible Note (20%)
  • Series Unknown (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Health Care
  • Pharmaceutical
  • Life Science
  • Machine Learning
  • Health Diagnostics
  • Medical
  • Neuroscience
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Viva Biotech frequently co-invest with?

BH
North America, Massachusetts, United States, Waltham
Co-Investments: 1
Tachyon Ventures
North America, California, United States, Los Angeles
Co-Investments: 2
Helicase Venture
North America, Massachusetts, United States, Boston
Co-Investments: 1
ExSight Ventures
North America, New York, United States, New York
Co-Investments: 1
IKJ Capital
South America, Sao Paulo, Brazil, São Paulo
Co-Investments: 1
FB
North America, California, United States, San Diego
Co-Investments: 1
Tech Coast Angels
North America, California, United States, Newport Beach
Co-Investments: 1
Kaitai Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Das & Co.
North America, New York, United States, New York
Co-Investments: 1
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 1

Which angels does Viva Biotech often collaborate with?

AI
Europe, Cyprus
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Viva Biotech?

Totient

Cambridge, Massachusetts, United States

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures.

Artificial Intelligence (AI)BiotechnologyLife ScienceMachine Learning
SeedSep 10, 2020
Amount Raised: $10,000,000
Triumvira Immunologics

Austin, Texas, United States

Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.

BiotechnologyClinical TrialsHealth Care
Series AAug 27, 2020
Amount Raised: $55,000,000
DTx Pharma

San Diego, California, United States

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

BiotechnologyPharmaceuticalTherapeutics
Series AJan 6, 2020
Amount Raised: $10,600,000
AcuraStem

Monrovia, California, United States

AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedicalNeuroscienceTherapeutics
Convertible NoteNov 8, 2019
Amount Raised: $1,000,000
Mebias Discovery

Philadelphia, Pennsylvania, United States

Mebias Discovery holds a game-changing platform to discover next generation.

GamingiOS
Series UnknownOct 14, 2019
Amount Raised: $3,500,000